Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.75
0.47%
After-hours: Aug 15, 2025, 04:10 PM EDT
Inhibikase Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -36.55M | -27.52M | -19.57M | -18.38M | -19.2M | -19.03M | -19.13M | -19.03M | -17.89M | -18.05M | -18.82M | -18.79M | -16.79M | -14.79M | -10.95M | -7.15M | -4.94M |
Depreciation & Amortization | 32.36K | 26.27K | 26.27K | 26.29K | 178.92K | 177.4K | 175.87K | 170.97K | 11.77K | 6.72K | 1.68K | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 10.13M | 8.14M | 354.4K | 336.16K | 430.31K | 500.15K | 478.26K | 450.27K | 458.19K | 458.15K | 623.63K | 874.26K | 1.06M | 1.53M | 1.42M | 1.21M | 1.03M |
Other Working Capital | -1.64M | -1.4M | -648.9K | 422.11K | 2.1M | 2.07M | 1.59M | 1.56M | 511.74K | 1.09M | 1.12M | 3.37M | 926.75K | -1.02M | -826.92K | -4M | -1.55M |
Other Non-Cash Items | 235.63K | -177.07K | 1.19M | -127.28K | 505.29K | 1.27M | 1.01M | 1.01M | 387.19K | 104.09K | 154.75K | 315.7K | 518.02K | 721.63K | 1.67M | 1.76M | 1.65M |
Deferred Income Tax | n/a | n/a | -223.18K | -223.18K | -886.45K | -1.24M | -1.01M | -1.01M | -350.09K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.85M | -1.13M | 592.44K | 1.52M | 2.58M | 234.76K | 280.41K | -1.19M | -1.97M | 171.18K | 183.2K | 3.23M | 910.57K | -1.76M | -3.29M | -4.87M | -2.56M |
Operating Cash Flow | -19.38M | -19.15M | -17.24M | -16.47M | -15.98M | -18.09M | -18.2M | -19.6M | -19.39M | -17.35M | -17.89M | -14.41M | -14.3M | -14.3M | -11.15M | -9.05M | -4.82M |
Capital Expenditures | n/a | n/a | 14.24K | 14.24K | n/a | n/a | 185.93K | -14.24K | -43.09K | -43.09K | -243.25K | -43.09K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | -14.24K | -14.24K | n/a | n/a | 14.24K | 14.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -52.02M | -60.46M | -19.14M | -19.95M | -16.25M | -29.43M | -36.39M | -55.17M | -58.1M | -36.49M | -20.73M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 39.84M | 23.45M | 18.78M | 34.13M | 30.45M | 41.1M | 39.38M | 20.37M | 20.74M | 4.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -452.02K | -3.31M | -5.43M | 11.63M | 11.62M | 9.09M | 26.77M | -11.02M | -11M | -5.16M | -20.73M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -12.64M | -37M | -358.07K | 14.18M | 14.18M | 11.66M | 18.74M | -19.25M | -21.84M | -16.01M | -20.97M | -43.09K | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -248.91K | -248.91K | -248.91K | 118.22K | -42.53K | -42.53K | -42.53K | -382.11K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 30.61K | n/a | -138.56K | -138.56K | -169.16K | -138.56K | n/a | n/a | -248.91K | -204.77K | 40.81M | 40.84M | 41.05M | 41M | 83.73K | -13.29K | n/a |
Financial Cash Flow | 103.11M | 103.48M | 3.66M | 3.47M | 192.98K | 8.41M | 8.34M | 8.34M | 8.13M | -658.45K | -453.68K | -423.79K | 41.3M | 41.09M | 55.98M | 55.88M | 14.41M |
Net Cash Flow | 71.09M | 47.33M | -13.95M | 1.18M | -1.6M | 1.98M | 9.08M | -30.31M | -32.65M | -33.56M | -39.06M | -14.62M | 27M | 26.8M | 44.83M | 46.83M | 9.6M |
Free Cash Flow | -19.38M | -19.15M | -17.23M | -16.45M | -15.98M | -18.09M | -18.01M | -19.61M | -19.43M | -17.39M | -18.13M | -14.45M | -14.3M | -14.3M | -11.15M | -9.05M | -4.82M |